Diabetic Nephropathy
📧 Sign up to get email alerts when something new happens for Diabetic Nephropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-08-20Clinical Trial Update: Efficacy of Telmisartan and the Combination of Telmisartan and Ramipril in type1 Diabetes Patients With Nephropathy [Phase 3]
A Phase 3 trial evaluating telmisartan alone and in combination with ramipril for diabetic nephropathy in type 1 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2008-08-19Clinical Trial Update: The Effect of Folic Acid Administration in the Progression of Microalbuminuria [NA]
This is a completed clinical trial evaluating folic acid for the progression of microalbuminuria in patients with diabetic nephropathy and h…
-
CLINICAL_TRIALS trial_result · 2008-07-15Clinical Trial Update: Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM) [Phase 4]
A Phase 4 trial (TANDEM) comparing Tarka (trandolapril/verapamil) with Lotrel (amlodipine/benazepril) in hypertensive, diabetic patients wit…
-
CLINICAL_TRIALS trial_result · 2008-07-15Clinical Trial Update: A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT) [Phase 4]
This update reports the completion of the Phase 4 BENEDICT trial evaluating prevention of kidney disease in diabetic patients. The study inc…
-
CLINICAL_TRIALS trial_result · 2008-05-08Clinical Trial Update: The Effect of Renin Angiotensin System Blockage (RAS) Blockade On PTX3 Levels In Diabetic Patients With Proteinuria [Phase 4]
A completed Phase 4 study assessing the effect of renin-angiotensin system blockade on PTX3 levels in diabetic patients with proteinuria.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-04-22Clinical Trial Update: Assessment of the Effect of Captopril Versus Combination of Captopril and Pentoxifylline on Reducing Proteinuria in Type 2 Diabetic Nephropathy [Phase 2, Phase 3]
This clinical trial update reports a comparison of captopril alone versus captopril plus pentoxifylline for reducing proteinuria in diabetic…
-
CLINICAL_TRIALS trial_result · 2008-01-15Clinical Trial Update: Anti-Nephropathic Effects of Chronic Intermittent Intravenous Insulin Therapy (CIIIT) [Phase 3]
A Phase 3 trial evaluating chronic intermittent intravenous insulin therapy for diabetic nephropathy and diabetic retinopathy has completed.
-
CLINICAL_TRIALS trial_result · 2007-12-12Clinical Trial Update: Study of the Safety of FG-3019 in Incipient Nephropathy Due to Type 1 or Type 2 Diabetes Mellitus [Phase 1]
Phase 1 safety study of FG-3019 (fresolimumab) in incipient diabetic nephropathy due to type 1 or type 2 diabetes has been completed.
-
CLINICAL_TRIALS trial_result · 2007-11-29Clinical Trial Update: Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy [Phase 1, Phase 2]
This report covers a Phase 1/Phase 2 clinical trial evaluating aliskiren, irbesartan, and their combination in hypertensive patients with ty…
-
CLINICAL_TRIALS trial_result · 2007-11-21Clinical Trial Update: Adiponectin in Obese Women With T2DN and Effects by RAS Blocker [NA]
This clinical trial update notes completion of a study evaluating adiponectin in obese women with type 2 diabetes and diabetic nephropathy, …
-
CLINICAL_TRIALS trial_result · 2007-11-14Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Daglutril Compared to Placebo on Top of Losartan in Type 2 Diabetics With Overt Nephropathy and Well Controlled Hypertension [Phase 2]
Phase 2 study evaluating the efficacy and safety of daglutril vs placebo added to losartan in adults with type 2 diabetes, overt nephropathy…
-
CLINICAL_TRIALS trial_result · 2007-11-12Clinical Trial Update: Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic Nephropathy [Phase 2, Phase 3]
Phase 2/3 trial evaluating the efficacy of N-Acetylcysteine for overt diabetic nephropathy has completed.
-
CLINICAL_TRIALS trial_result · 2007-11-08Clinical Trial Update: Long-Term Effect of Soy Consumption on Cardio-Renal Indices and CRP in Type 2diabetes With Nephropathy [Phase 1]
A Phase 1 trial evaluated the long-term effects of soy consumption on cardio-renal indices and C-reactive protein in individuals with type 2…
-
CLINICAL_TRIALS trial_result · 2007-10-05Clinical Trial Update: To Determine the Effects of Avosentan on Doubling of Serum Creatinine, End Stage Renal Disease and Death in Diabetic Nephropathy [Phase 3]
Phase 3 trial of avosentan for diabetic nephropathy was terminated; the update does not provide results.
-
CLINICAL_TRIALS trial_result · 2007-08-02Clinical Trial Update: Angiotensin II Antagonism of TGF-Beta 1 [NA]
Clinical trial on Angiotensin II antagonism of TGF-Beta 1 in diabetic nephropathy and hypertension completed.
-
CLINICAL_TRIALS trial_result · 2007-06-08Clinical Trial Update: Chicken-Diet vs. Enalapril to Reduce Albuminuria [NA]
A completed clinical trial comparing a chicken-based diet to enalapril for reducing albuminuria in people with microalbuminuria and diabetic…
-
CLINICAL_TRIALS trial_result · 2007-05-10Clinical Trial Update: Doxazosin Effects on ABPM in Hypertensive Patients With Diabetic Nephropathy [Phase 4]
Phase 4 clinical trial update on doxazosin effects on ambulatory blood pressure monitoring in hypertensive patients with diabetic nephropath…
-
CLINICAL_TRIALS trial_result · 2007-03-19Clinical Trial Update: Effect of Low Protein Diet in Preventing the Progression of Diabetic Nephropathy [NA]
The clinical trial evaluating a low-protein diet to prevent the progression of diabetic nephropathy has been terminated.
-
CLINICAL_TRIALS trial_result · 2007-01-08Clinical Trial Update: Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 Diabetes
This clinical trial update notes that the Higashi-Saitama trial evaluating pioglitazone for cardiovascular outcomes in patients with type 2 …
-
CLINICAL_TRIALS trial_result · 2006-11-23Clinical Trial Update: Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease [NA]
This clinical trial update discusses the maximal dose of an ACE inhibitor being studied for treating diabetic kidney disease, with the trial…
-
CLINICAL_TRIALS trial_result · 2006-10-17Clinical Trial Update: Maximizing the Benefit of Renin-Angiotensin Blocking Drugs in Diabetic Renal Disease. [NA]
A completed clinical trial update evaluating how renin-angiotensin blocking drugs may maximize benefits in diabetic nephropathy.
-
CLINICAL_TRIALS trial_result · 2006-10-09Clinical Trial Update: Olmesartan Medoxomil and Diabetic Nephropathy [Phase 3]
A Phase 3 trial evaluating Olmesartan Medoxomil for diabetic nephropathy in type 2 diabetes has been completed.
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: Soy Protein in Early Diabetic Nephropathy [Phase 1, Phase 2]
This document reports a completed Phase 1/Phase 2 clinical trial evaluating soy protein in patients with early diabetic nephropathy. The stu…
-
CLINICAL_TRIALS trial_result · 2006-08-07Clinical Trial Update: Effects of Losartan on Insulin Sensitivity and Secretion in Type 2 Diabetes and Nephropathy [NA]
A completed clinical trial evaluated how losartan affects insulin sensitivity and secretion in individuals with type 2 diabetes and diabetic…
-
CLINICAL_TRIALS trial_result · 2006-05-18Clinical Trial Update: Optimal Dose of Irbesartan for Renoprotection in Type 2 Diabetic Patients With Persistent Microalbuminuria [Phase 4]
A Phase 4 trial completed evaluating the optimal dose of irbesartan for renoprotection in adults with type 2 diabetes mellitus and persisten…